# TEKAMLO
> **NDA022545** · New Drug Application · Sponsor: NOVARTIS · Approved 2010-08-26
## Drug
- **FDA Application Number:** NDA022545
- **Application type:** New Drug Application
- **Brand name:** TEKAMLO
- **Generic name:** Aliskiren Hemifumarate
- **Active ingredients:** ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** NOVARTIS
- **First approval:** 2010-08-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022545)
---
*AI Analytics · CC0 1.0*